A new publication involving the peptide GHK was released on October 1, 2026. The paper, titled "Peptide-Activated ECM-Mimicking Channeled OPF Cryogel Scaffold for Spinal Cord Lesion Bridging: Development and Pilot Study in Minipigs," appeared in the journal Macromolecular Bioscience.
The publication describes a scaffold development approach incorporating GHK as part of an extracellular matrix mimicking design. It is identified as a pilot study conducted in minipigs. No results, outcomes, or efficacy data from this study are included in this brief, as none were provided in the source event information.
This entry reflects the existence and placement of the publication only. Readers interested in the specific methods, findings, or conclusions of the study should consult the original article directly through the listed source link.
GHK remains classified as approved under current regulatory status. This publication represents academic research activity involving the compound rather than a regulatory or clinical trial action. For more background on GHK, including its general profile and context, readers can refer to the compound overview.